Related references
Note: Only part of the references are listed.Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast Cancer
Rosaria Benedetti et al.
CANCERS (2021)
Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling
Xiang Ding et al.
BIOENGINEERED (2021)
Bone marrow-derived mesenchymal stem cells repair severe acute pancreatitis by secreting miR-181a-5p to target PTEN/Akt/TGF-β1 signaling
Han-Yu Li et al.
CELLULAR SIGNALLING (2020)
Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer
Elena Alexandrova et al.
CELLS (2020)
LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15
Yun Liu et al.
BMC MOLECULAR AND CELL BIOLOGY (2020)
Cryptanshinone Inhibits the Glycolysis and Inhibits Cell Migration Through PKM2/β-Catenin Axis in Breast Cancer
Jiefeng Zhou et al.
ONCOTARGETS AND THERAPY (2020)
MicroRNA-181a-5p and microRNA-181a-3p cooperatively restrict vascular inflammation and atherosclerosis
Yingxue Su et al.
CELL DEATH & DISEASE (2019)
NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway
Cheng-Liang Yang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Altered Expression of miR-181a-5p and miR-23a-3p Is Associated With Obesity and TNFα-Induced Insulin Resistance
Javier Lozano-Bartolome et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Ndrg2 deficiency ameliorates neurodegeneration in experimental autoimmune encephalomyelitis
Thuong Manh Le et al.
JOURNAL OF NEUROCHEMISTRY (2018)
miR-181a-5p Promotes Proliferation and Invasion and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A)
Meng Yang et al.
ONCOLOGY RESEARCH (2018)
PTEN: Tumor Suppressor and Metabolic Regulator
Chien-Yu Chen et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
The hsa-miR-181a-5p reduces oxidation resistance by controlling SECISBP2 in osteoarthritis
Jianli Xue et al.
BMC MUSCULOSKELETAL DISORDERS (2018)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Awareness and current knowledge of breast cancer
Muhammad Akram et al.
BIOLOGICAL RESEARCH (2017)
Loss of NDRG2 Expression Confers Oral Squamous Cell Carcinoma with Enhanced Metastatic Potential
Tomohiro Tamura et al.
CANCER RESEARCH (2017)
miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation
Yushuai Mi et al.
CANCER LETTERS (2017)
Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer
Wei Hu et al.
ONCOTARGET (2016)
Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response
Kheshwant S. Gill et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2016)
Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer
Vera Kloten et al.
PLOS ONE (2016)
MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells
Zhongliang Ma et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2015)
miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14
Yiyi Li et al.
CANCER RESEARCH (2015)
Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression
Xinyuan Xu et al.
ONCOTARGET (2015)
MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets
R. Su et al.
ONCOGENE (2015)
N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma
Ji Ma et al.
BREAST CANCER RESEARCH (2014)
N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling
Myung-Jin Kim et al.
CANCER LETTERS (2014)
MicroRNA Profiling Implies New Markers of Chemoresistance of Triple-Negative Breast Cancer
Mao Ouyang et al.
PLOS ONE (2014)
Loss of NDRG2 expression activates PI3K-AKT signalling via PTEN phosphorylation in ATLL and other cancers
Shingo Nakahata et al.
NATURE COMMUNICATIONS (2014)
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Marilena V. Iorio et al.
EMBO MOLECULAR MEDICINE (2012)
Inhibition of Endothelial Cell Proliferation and Tumor Angiogenesis by Up-Regulating NDRG2 Expression in Breast Cancer Cells
Ji Ma et al.
PLOS ONE (2012)
Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer
Anders Lorentzen et al.
BMC CANCER (2011)
NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma
Hiroshi Furuta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
Share Paper
